WASHINGTON, D.C., December 12, 2020 (LifeSiteNews) — The U.S. Food and Drug Administration (FDA) announced Friday that it has approved the emergency use of the Pfizer-BioNTech COVID-19 vaccine for individuals over 16 years of age.
Although the Pfizer vaccine was not developed using a cell line derived from an aborted baby, it was tested — that is, the laboratory phase which verifies the quality of the vaccine on cell tissues — using such a cell line, HEK-293, reports Children of God for Life.
The U.S. government is set to receive 100 million doses of the two-shot Pfizer vaccine by March. A shipment of about 2.9 million doses of the vaccine, which must be stored at a frigid -60 to -80 degrees Celsius, will be delivered around the United States over the next week, according to The New York Times.
It newspaper also reported that, according to an unnamed “senior administration official,” White House chief of staff Mark Meadows told FDA commissioner Dr. Stephen Hahn on Friday morning, in the words of the New York Times, “to consider looking for his next job if he didn’t get the emergency approval done on Friday.” Via – Lifesite News